    <SEC-DOCUMENT>0001104659-24-067915-index.html : 20240604
    <SEC-HEADER>0001104659-24-067915.hdr.sgml : 20240604
    <ACCEPTANCE-DATETIME>20240603174529
    ACCESSION NUMBER:		0001104659-24-067915
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20231231
    FILED AS OF DATE:		20240604
    DATE AS OF CHANGE:		20240603
    EFFECTIVENESS DATE:		20240604

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Akari Therapeutics Plc
    		CENTRAL INDEX KEY:			0001541157
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				981034922
    		STATE OF INCORPORATION:			X0

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36288
    		FILM NUMBER:		241015239

    	BUSINESS ADDRESS:
    		STREET 1:		22 BOSTON WHARF ROAD
    		STREET 2:		FL 7
    		CITY:			BOSTON
    		STATE:			MA
    		ZIP:			02210
    		BUSINESS PHONE:		(646) 350-0702

    	MAIL ADDRESS:
    		STREET 1:		22 BOSTON WHARF ROAD
    		STREET 2:		FL 7
    		CITY:			BOSTON
    		STATE:			MA
    		ZIP:			02210

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Celsus Therapeutics Plc.
    		DATE OF NAME CHANGE:	20130621

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Morria Biopharmaceuticals PLC
    		DATE OF NAME CHANGE:	20120201
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>tm2416228-2_ars.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: tm2416228-2_ars.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>